Clinical Trial Update: A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD) [Phase 3]

View source ↗

Summary

A Phase 3 study comparing dulaglutide with insulin glargine in type 2 diabetes patients with moderate to severe chronic kidney disease has completed, with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Dulaglutide (dulaglutide)
• Insulin Glargine (insulin glargine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes, Chronic Kidney Disease | Phase 3 | Status: COMPLETED | Results posted: 2017-07-24